Gilead Sciences Spikes Amid CVS Formulary Status
January 05, 2015 at 12:32 PM EST
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) spiked up over 3 percent Monday amid news that CVS Health Corp (NYSE: CVS) gave ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.